Precigen, Inc. raised its stock price target following news of drug approval.
1 report, 1 independent
Updated Aug 26
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Precigen, Inc. raised its stock price target following news of drug approval.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Precigen, Inc
company in Blacksburg, United States
Nothing else this week.
Coverage
Newest first; wire copies grouped- Insider MonkeyCitizens JMP Raises PT on Precigen from $6 to $8, Keeps Outperform Rating Precigen Inc. (NASDAQ:PGEN) is one of the 11 Low Price High Volume Stocks to Buy According to Analysts. On August 18, Citizen